Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
出版年份 2017 全文链接
标题
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
作者
关键词
Cancer treatment, Brainstem, Histones, Apoptosis, Drug therapy, Mouse models, Toxicity, Acetylation
出版物
PLoS One
Volume 12, Issue 1, Pages e0169485
出版商
Public Library of Science (PLoS)
发表日期
2017-01-10
DOI
10.1371/journal.pone.0169485
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
- (2016) Hamid Nikbakht et al. Nature Communications
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Tumor location, but not H3.3K27M, significantly influences the blood–brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma
- (2015) Ergys Subashi et al. JOURNAL OF NEURO-ONCOLOGY
- Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
- (2015) Catherine S Grasso et al. NATURE MEDICINE
- A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent
- (2015) Kyle G. Halvorson et al. PLoS One
- ACVR1Mutations in DIPG: Lessons Learned from FOP
- (2014) Kathryn R. Taylor et al. CANCER RESEARCH
- Diffuse intrinsic pontine glioma: a reassessment
- (2014) Nathan J. Robison et al. JOURNAL OF NEURO-ONCOLOGY
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
- (2014) Pawel Buczkowicz et al. NATURE GENETICS
- Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
- (2014) Kathryn R Taylor et al. NATURE GENETICS
- Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
- (2014) Adam M Fontebasso et al. NATURE GENETICS
- Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
- (2013) Sebastian Bender et al. CANCER CELL
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
- (2013) K.-M. Chan et al. GENES & DEVELOPMENT
- Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology
- (2013) Kristin M. Schroeder et al. PEDIATRIC RESEARCH
- PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
- (2013) Kelly L. Barton et al. PLoS One
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
- (2013) P. W. Lewis et al. SCIENCE
- Profile of panobinostat and its potential for treatment in solid tumors: an update
- (2013) Madhurima Anne et al. OncoTargets and Therapy
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
- (2012) Dong-Anh Khuong-Quang et al. ACTA NEUROPATHOLOGICA
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- HDAC inhibitor-based therapies: Can we interpret the code?
- (2012) Maria New et al. Molecular Oncology
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
- (2011) M. Monje et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Convection-enhanced delivery for the treatment of brain tumors
- (2009) Waldemar Debinski et al. Expert Review of Neurotherapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started